CIK: 1760102 - Address: C/O Alaunos Therapeutics, Inc., 2617 Bissonnet St, Suite 225, Houston, TX 770005
5 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

12/23/20 17:26
12/22/20
TCRRTcr2 Therapeutics Inc.DEHealthBioPrdBiological Products, (No DiagHofmeister RobertMAOChief ScM.d50.7400071846D
11/13/20 16:08
11/12/20
TCRRTcr2 Therapeutics Inc.DEHealthBioPrdBiological Products, (No DiagHofmeister RobertMAOChief ScM.d150.740002010639D
11/13/20 16:08
11/12/20
TCRRTcr2 Therapeutics Inc.DEHealthBioPrdBiological Products, (No DiagHofmeister RobertMAOChief ScS.d-50225.100-20-3439D
11/2/20 14:00
10/29/20
TCRRTcr2 Therapeutics Inc.DEHealthBioPrdBiological Products, (No DiagHofmeister RobertMAOChief ScM.d150.740002010639D
11/2/20 14:00
10/29/20
TCRRTcr2 Therapeutics Inc.DEHealthBioPrdBiological Products, (No DiagHofmeister RobertMAOChief ScS.d-38219.100-20-3439D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact